Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/07/043727
CTRI/2022/07/043727
Recruiting
未知

A controlled case study of inflammatory markers with nadi tarangini as a screening test in pranavaha srotas dushti with special reference to COPD.

Dr Sandeep Govind Dahilekar0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: I798- Other disorders of arteries, arterioles and capillaries in diseases classified elsewhereHealth Condition 2: J708- Respiratory conditions due to other specified external agents

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: I798- Other disorders of arteries, arterioles and capillaries in diseases classified elsewhereHealth Condition 2: J708- Respiratory conditions due to other specified external agents
Sponsor
Dr Sandeep Govind Dahilekar
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Dr Sandeep Govind Dahilekar

Eligibility Criteria

Inclusion Criteria

  • •1\. Acute Respiratory Diseases \- Acute Bronchitis, SARsCOV2, Septic shock, Pneumonia, Emphysema, Bronchiectasis.
  • •2\. Chronic Respiratory Diseases \- Post Covid19, Pulmonary fibrosis (Scarring \& thickening of lung tissues), Asthma, Chronic obstructive pulmonary diseases (COPD), Chronic Bronchitis, Occupational lung diseases, Chronic Cigarette smoker, Pulmonary hypertension, Pleural effusion, Tuberculosis, Pleural effusion (Infectious).

Exclusion Criteria

  • •1\. Patients below age 18 yrs. and over 70 yrs.
  • •2\. Lungs cancer, Lungs transplant, Trauma, Lungs aspirates (Vomits), Cystic fibrosis (Genetical diseases), Pleural effusion (Non\-Infectious, Malignancy), Depression induced ARDS.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Examination of inflammatory markers associated with Total Knee Replacement surgery, and the association with coagulopathies (bleeding/clotting disorders)
ACTRN12617000444381Orthopaedic Research Institute of Queensland (ORIQL)20
Active, not recruiting
Phase 1
Evaluation of inflammatory markers in patients undergoing a short-term aerobic exercise program while hospitalized due to acute exacerbation of COPDChronic obstructive pulmonary disease with acute lower respiratory infectionJ44.0
RBR-7yv765Faculdade de Medicina de Botucatu /UNESP
Recruiting
Phase 3
Clinical trial on respiratory illness patientsHealth Condition 1: J208- Acute bronchitis due to other specified organisms
CTRI/2021/03/032056Zum Heilen Diagnostic Therapeutics ZH DT
Completed
Not Applicable
Assessment of inflammatory markers in patients with ulcerative colitis treated with tofacitinibulcerative colitis10017969
NL-OMON40572Academisch Medisch Centrum30
Active, not recruiting
Phase 1
Examining the effects of eye drops on changes in inflammation on the surface of the eyeGlaucoma is the condition that is being treated by these eye drops - however the study is aimed at measuring the amount of inflammation that develops on the surface of the eye when these drops are usedMedDRA version: 14.1 Level: HLGT Classification code 10018307 Term: Glaucoma and ocular hypertension System Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2013-000581-10-GBottingham University NHS Trust100